NDC 68682-0309-30
budesonide 9 mg/1 TABLET, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
68682-0309-30
Generic Name
budesonide
Brand Name
budesonide
Strength
9 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Oceanside Pharmaceuticals
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Budesonide extended-release tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. Budesonide extended-release tablets are a glucocorticosteroid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. ( 1 )
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All budesonide Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other budesonide NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 68682-0309-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).